Filing Flows

Filing Flows › Consumer Staples › cbdMD (YCBD)

cbdMD (YCBD) earnings and revenue breakdown

Latest: Q3 FY26 · 10-Q filed Aug 13, 2026 · cbdMD (YCBD) Q3 FY26 earnings results →

Q3 FY26 Revenue up 21% year over year to $5.6M · 20¢ of every $1 of revenue lost · operating margin -20.4%

cbdMD made $5.6M in Q3 FY26 (+21% Y/Y). Operating margin -20.4%, net loss $1.1M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.

Revenue$5.6M
Year over year+21%
Operating margin-20.4%
Net earnings−$1.1M
Operating cash flow−$442K

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $5.6M in Q3 FY26, up 21% year over year and down 2% from the previous quarter.

Gross margin was 54.7%, down 6.8 points from Q3 FY25. Operating costs exceeded revenue by $1.1M, an operating margin of -20.4%. Operating expenses grew 12% against revenue growth of 21%. The quarter ended with a net loss of $1.1M, wider than the previous quarter's $798K loss.

Operating cash flow was −$442K. Non-cash charges added back $259K of depreciation and amortization. Working capital and other items added $426K. Capital expenditures of $18K exceeded it, leaving free cash flow of −$460K.

Quarterly history

cbdMD revenue by quartercbdMD revenue by quarter$4.6MQ4 FY24$4.7MQ2 FY25$4.6MQ3 FY25$4.7MQ4 FY25$5.0MQ1 FY26$5.6MQ2 FY26$5.6MQ3 FY26
cbdMD net earnings by quartercbdMD net earnings by quarter−$153KQ4 FY24−$481KQ2 FY25−$895KQ3 FY25−$680KQ4 FY25−$283KQ1 FY26−$798KQ2 FY26−$1.1MQ3 FY26
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 FY2610-QAug 13, 2026$5.6M+21%-20.4%−$1.1M−$442K
Q2 FY2610-QMay 14, 2026$5.6M+19%-14.2%−$798K−$722K
Q1 FY2610-QFeb 17, 2026$5.0M-2%-5.7%−$283K−$812K
Q4 FY2510-KDec 19, 2025$4.7M+4%-14.5%−$680K−$241K
Q3 FY2510-QAug 14, 2025$4.6M-11%-19.6%−$895K−$704K
Q2 FY2510-QMay 15, 2025$4.7M+8%-10.2%−$481K−$189K
Q4 FY2410-KDec 18, 2024$4.6M-20%-6.9%−$153K$167K

Charts

cbdMD: revenue growth, year over year and quarter over quartercbdMD: revenue growth, year over year and quarter over quarterY/YQ/Q-20%Q4 FY24+8%+4%Q2 FY25-11%-3%Q3 FY25+4%+2%Q4 FY25-2%+6%Q1 FY26+19%+12%Q2 FY26+21%-2%Q3 FY26
Latest (Q3 FY26): Y/Y +21%, Q/Q -2%.
cbdMD: where the cash came from (+) and went (−), TTM to Q3 FY26cbdMD: where the cash came from (+) and went (−), TTM to Q3 FY26Shares issued$3.5MOperating cash flow−$2.2MCash drawn (+) / kept (−)−$1.1MCapital spending−$191KOther financing−$120KOther investing$56K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
cbdMD: profit against cash, quarter by quartercbdMD: profit against cash, quarter by quarterNet incomeOperating cash flow−$153K$167KQ4 FY24$15K−$318KQ1 FY25−$481K−$189KQ2 FY25−$895K−$704KQ3 FY25−$680K−$241KQ4 FY25−$283K−$812KQ1 FY26−$798K−$722KQ2 FY26−$1.1M−$442KQ3 FY26
Latest (Q3 FY26): Net income −$1.1M, Operating cash flow −$442K.
cbdMD: diluted shares by fiscal yearcbdMD: diluted shares by fiscal year45MFY2055MFY211MFY222MFY231MFY244MFY25
-91.1% since FY20: buybacks shrank the count.
cbdMD in its industry: growth against margin (15 companies, SIC 2844)cbdMD in its industry: growth against margin (15 companies, SIC 2844)revenue growth, year over year →↑ operating marginmedian +3%median 7%CLKVUEELCOTYEPCELFIPARSLSNAXILUGBNKKDQWSKARXSHFHYCBD (+21%, -20%)
Perfumes, Cosmetics & Other Toilet Preparations; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About cbdMD

cbdMD, Inc. (“cbdMD,” “we,” “us,” “our,” or the “Company”) is a corporation organized under the laws of the State of North Carolina, formed on March 17, 2015 as Level Beauty Group, Inc. In November 2016, we changed the name of the Company to Level Brands, Inc., and on May 1, 2019, we changed the name of our Company to cbdMD, Inc. We operate from offices located in Charlotte, North Carolina. Our fiscal year end is established as September 30. There have been no material changes in the Company's significant accounting policies from those previously disclosed in the Annual Report as of and for the fiscal year ended September 30, 2025 as filed on Form 10 -K, as amended (the “2025 10 -K”).

In its own words, from its 10-Q, filed Aug 13, 2026.

cbdMD against its Perfumes, Cosmetics & Other Toilet Preparations peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +21% against the peers' median +3%. Operating margin: -20.4% against the peers' median 11.0%.

CompanyQuarterRevenueY/YOp. margin
YCBD cbdMDQ3 FY26$5.6M+21%-20.4%
CL Colgate PalmoliveQ3 2026$5.4B+5%20.3%
KVUE KenvueQ3 2026$3.9B+3%18.2%
EL Estee Lauder CompaniesQ1 FY27$3.7B+7%11.0%
COTY CotyQ1 FY27$1.6B-1%11.0%
EPC Edgewell Personal CareQ3 FY26$570M+2%4.4%
ELF e.l.f. BeautyQ2 FY27$521M+51%10.1%
IPAR InterparfumsQ3 2026$430M0%27.4%
SLSN SolesenceQ2 2026$15.3M-25%0.8%

Source: cbdMD 10-Q on SEC EDGAR · CIK 1644903 · Perfumes, Cosmetics & Other Toilet Preparations

13F: who owns YCBD and who is buying

Largest holders of YCBD (13F)Largest holders of YCBD (13F)Vanguard Group$133KWorth Venture Partners, LLC$124KCSS LLC$93KVanguard Capital Management LLC$81KAlesco Advisors LLC$46KChicago Partners Investment Group…$45KXTX Topco$42KChapin Davis$37KJane Street Group, LLC$37KVanguard Fiduciary Trust$32K
Funds' net buying of YCBD by quarter (13F)Funds' net buying of YCBD by quarter (13F)$428K2025-06−$59K2025-09$31K2025-12−$125K2026-03−$16K2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on YCBD

History

Every quarter: Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results · Q4 FY24 results

Compare YCBD with

中文版：cbdMD（YCBD）财报

Español · Français